Literature DB >> 25647864

Could Delaware's medical marijuana law reduce harms from opioid analgesics?

Marcus A Bachhuber, Brendan Saloner, Chinazo O Cunningham, Jordyn Feingold, Colleen L Barry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25647864

Source DB:  PubMed          Journal:  Del Med J        ISSN： 0011-7781


× No keyword cloud information.
  3 in total

Review 1.  Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.

Authors:  Henry L Blanton; Jennifer Brelsfoard; Nathan DeTurk; Kevin Pruitt; Madhusudhanan Narasimhan; Daniel J Morgan; Josée Guindon
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

2.  Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.

Authors:  Luis E Segura; Christine M Mauro; Natalie S Levy; Nicole Khauli; Morgan M Philbin; Pia M Mauro; Silvia S Martins
Journal:  JAMA Netw Open       Date:  2019-07-03

3.  Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.

Authors:  Chinazo O Cunningham; Joanna L Starrels; Chenshu Zhang; Marcus A Bachhuber; Nancy L Sohler; Frances R Levin; Haruka Minami; Deepika E Slawek; Julia H Arnsten
Journal:  BMJ Open       Date:  2020-12-29       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.